• Microbot Medical named Alon Tamir vice president of sales for Europe, Middle East, Asia.
• Tamir brings more than two decades of medical-technology experience across diagnostic, interventional, robotics markets.
• Role targets commercial readiness for international expansion, with continued priority on US market.
• Microbot cited Europe peripheral endovascular procedure volume of about 2,300,000, similar to US levels.
• Company expects CE mark by end of 2026 to support entry into additional markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604300830PRIMZONEFULLFEED9710168) on April 30, 2026, and is solely responsible for the information contained therein.